Exome Sequencing Reveals AMER1 as a Frequently Mutated Gene in Colorectal Cancer

enthalten in: Clinical cancer research | 2015

von Sanz-Pamplona, R. | Lopez-Doriga, A. | Paré-Brunet, L. | +16

Optimizing Anti-EGFR Therapy in Colorectal Cancer

enthalten in: Clinical cancer research | 2015

von Salazar, R. | Ciardiello, F.

New Approaches but the Same Flaws in the Search for Prognostic Signatures

enthalten in: Clinical cancer research | 2014

von Salazar, R. | Tabernero, J.

Sorafenib in Combination with Oxaliplatin, Leucovorin, and Fluorouracil (Modified FOLFOX6) as First-line Treatment of Metastatic Colorectal Cancer: The RESPECT Trial

enthalten in: Clinical cancer research | 2013

von Tabernero, J. | Garcia-Carbonero, R. | Cassidy, J. | +17

Phase I Pharmacokinetic-Pharmacodynamic Study of EKB-569, an Irreversible Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Combination with Irinotecan, 5-Fluorouracil, and Leucovorin (FOLFIRI) in First-Line Treatment of Patients with Metastatic Colorectal Cancer

enthalten in: Clinical cancer research | 2008

von Folprecht, G. | Tabernero, J. | Köhne, C. | +13

Phase I Clinical and Pharmacokinetic Study of Kahalalide F Administered Weekly as a 1-Hour Infusion to Patients with Advanced Solid Tumors

enthalten in: Clinical cancer research | 2008

von Pardo, B. | Paz-Ares, L. | Tabernero, J. | +9

Clinical Trials - A Phase I Clinical and Pharmacokinetic Study of Ro 31-7453 Given as a 7- or 14-Day Oral Twice Daily Schedule Every 4 Weeks in Patients with Solid Tumors.

enthalten in: Clinical cancer research | 2004

von Salazar, R. | Bissett, D. | Twelves, C. | +6

Clinical Trials - Phase I Pharmacological and Bioavailability Study of Oral Diflomotecan (BN80915), a Novel E-Ring-modified Camptothecin Analogue in Adults with Solid Tumors.

enthalten in: Clinical cancer research | 2003

von Gelderblom, H. | Salazar, R. | Verweij, J. | +6